TY - JOUR
TI - Wells’ syndrome with a clinicopathological correlation associated with mantle-cell lymphoma
AU - Pessach, I.
AU - Petevi, K.
AU - Gkirkas, K.
AU - Stamouli, M.
AU - Constantinou, P.
AU - Rontogianni, D.
AU - Dimitriadis, G.
AU - Tsirigotis, P.
JO - Clinical Lymphoma Myeloma and Leukemia
PY - 2016
VL - 57
TODO - 11
SP - 2702-2704
PB - Taylor and Francis Ltd.
SN - null
TODO - 10.3109/10428194.2016.1157876
TODO - CD20 antigen;  CD23 antigen;  CD5 antigen;  cisplatin;  cyclin D1;  cyclophosphamide;  cytarabine;  doxorubicin;  etoposide;  hemoglobin;  ibrutinib;  methylprednisolone;  prednisolone;  rituximab;  vincristine;  antineoplastic agent;  cyclophosphamide;  doxorubicin;  monoclonal antibody;  prednisone;  R-CHOP protocol;  vincristine, adult;  allogeneic stem cell transplantation;  anemia;  blood cell count;  bone marrow biopsy;  cancer combination chemotherapy;  cancer regression;  case report;  cell infiltration;  chromatin;  clinical evaluation;  clinical examination;  clinical feature;  computer assisted tomography;  disease association;  disease course;  eosinophil;  erythema;  fever;  histiocyte;  histopathology;  hospital admission;  human;  human tissue;  immunohistochemistry;  immunophenotyping;  inflammatory cell;  Letter;  lower limb;  lymphadenopathy;  lymphocyte;  lymphoid cell;  maintenance therapy;  male;  mantle cell lymphoma;  medical history;  microscopy;  middle aged;  multiple cycle treatment;  papule;  priority journal;  salvage therapy;  skin defect;  skinfold thickness;  splenomegaly;  subcutaneous tissue;  Wells syndrome;  cellulitis;  complication;  eosinophilia;  mantle cell lymphoma;  pathology, Antibodies, Monoclonal, Murine-Derived;  Antineoplastic Combined Chemotherapy Protocols;  Cellulitis;  Cyclophosphamide;  Doxorubicin;  Eosinophilia;  Humans;  Lymphoma, Mantle-Cell;  Male;  Middle Aged;  Prednisone;  Vincristine
TODO - null
ER -